Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 109
Inquire Before Buying

Global Metastatic Prostate Cancer Treatment Scope and Market Size

Metastatic Prostate Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Prostate Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Mono

- Combination

- Mono/Combination

Segment by Application

- Hospital

- Drug Store

- Online Pharmacy

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- AB Science

- BeiGene

- eFFECTOR Therapeutics

- Immunomedics(Gilead Sciences, Inc.)

- Myovant Biosciences

- SeleXel

- Zenith Epigenetics Ltd.

- VasGene Therapeutics, Inc.

- Telix Pharmaceuticals

- Arvinas Inc.

- Amgen

- Genentech

Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mono
1.2.3 Combination
1.2.4 Mono/Combination
1.3 Market by Application
1.3.1 Global Metastatic Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Prostate Cancer Treatment Industry Dynamic
2.3.1 Metastatic Prostate Cancer Treatment Market Trends
2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
2.3.4 Metastatic Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2020
3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Metastatic Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Prostate Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Prostate Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Details
11.1.2 AB Science Business Overview
11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.1.5 AB Science Recent Development
11.2 BeiGene
11.2.1 BeiGene Company Details
11.2.2 BeiGene Business Overview
11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.2.5 BeiGene Recent Development
11.3 eFFECTOR Therapeutics
11.3.1 eFFECTOR Therapeutics Company Details
11.3.2 eFFECTOR Therapeutics Business Overview
11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.3.5 eFFECTOR Therapeutics Recent Development
11.4 Immunomedics(Gilead Sciences, Inc.)
11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details
11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development
11.5 Myovant Biosciences
11.5.1 Myovant Biosciences Company Details
11.5.2 Myovant Biosciences Business Overview
11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.5.5 Myovant Biosciences Recent Development
11.6 SeleXel
11.6.1 SeleXel Company Details
11.6.2 SeleXel Business Overview
11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.6.5 SeleXel Recent Development
11.7 Zenith Epigenetics Ltd.
11.7.1 Zenith Epigenetics Ltd. Company Details
11.7.2 Zenith Epigenetics Ltd. Business Overview
11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.7.5 Zenith Epigenetics Ltd. Recent Development
11.8 VasGene Therapeutics, Inc.
11.8.1 VasGene Therapeutics, Inc. Company Details
11.8.2 VasGene Therapeutics, Inc. Business Overview
11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.8.5 VasGene Therapeutics, Inc. Recent Development
11.9 Telix Pharmaceuticals
11.9.1 Telix Pharmaceuticals Company Details
11.9.2 Telix Pharmaceuticals Business Overview
11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.9.5 Telix Pharmaceuticals Recent Development
11.10 Arvinas Inc.
11.10.1 Arvinas Inc. Company Details
11.10.2 Arvinas Inc. Business Overview
11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.10.5 Arvinas Inc. Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.11.5 Amgen Recent Development
11.12 Genentech
11.12.1 Genentech Company Details
11.12.2 Genentech Business Overview
11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.12.5 Genentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mono
Table 3. Key Players of Combination
Table 4. Key Players of Mono/Combination
Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Metastatic Prostate Cancer Treatment Market Trends
Table 12. Metastatic Prostate Cancer Treatment Market Drivers
Table 13. Metastatic Prostate Cancer Treatment Market Challenges
Table 14. Metastatic Prostate Cancer Treatment Market Restraints
Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metastatic Prostate Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Metastatic Prostate Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Metastatic Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AB Science Company Details
Table 63. AB Science Business Overview
Table 64. AB Science Metastatic Prostate Cancer Treatment Product
Table 65. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. AB Science Recent Development
Table 67. BeiGene Company Details
Table 68. BeiGene Business Overview
Table 69. BeiGene Metastatic Prostate Cancer Treatment Product
Table 70. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. BeiGene Recent Development
Table 72. eFFECTOR Therapeutics Company Details
Table 73. eFFECTOR Therapeutics Business Overview
Table 74. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product
Table 75. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. eFFECTOR Therapeutics Recent Development
Table 77. Immunomedics(Gilead Sciences, Inc.) Company Details
Table 78. Immunomedics(Gilead Sciences, Inc.) Business Overview
Table 79. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product
Table 80. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. Immunomedics(Gilead Sciences, Inc.) Recent Development
Table 82. Myovant Biosciences Company Details
Table 83. Myovant Biosciences Business Overview
Table 84. Myovant Biosciences Metastatic Prostate Cancer Treatment Product
Table 85. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. Myovant Biosciences Recent Development
Table 87. SeleXel Company Details
Table 88. SeleXel Business Overview
Table 89. SeleXel Metastatic Prostate Cancer Treatment Product
Table 90. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. SeleXel Recent Development
Table 92. Zenith Epigenetics Ltd. Company Details
Table 93. Zenith Epigenetics Ltd. Business Overview
Table 94. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product
Table 95. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Zenith Epigenetics Ltd. Recent Development
Table 97. VasGene Therapeutics, Inc. Company Details
Table 98. VasGene Therapeutics, Inc. Business Overview
Table 99. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. VasGene Therapeutics, Inc. Recent Development
Table 101. Telix Pharmaceuticals Company Details
Table 102. Telix Pharmaceuticals Business Overview
Table 103. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product
Table 104. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Telix Pharmaceuticals Recent Development
Table 106. Arvinas Inc. Company Details
Table 107. Arvinas Inc. Business Overview
Table 108. Arvinas Inc. Metastatic Prostate Cancer Treatment Product
Table 109. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Arvinas Inc. Recent Development
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Metastatic Prostate Cancer Treatment Product
Table 114. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 115. Amgen Recent Development
Table 116. Genentech Company Details
Table 117. Genentech Business Overview
Table 118. Genentech Metastatic Prostate Cancer Treatment Product
Table 119. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 120. Genentech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mono Features
Figure 3. Combination Features
Figure 4. Mono/Combination Features
Figure 5. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Drug Store Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Metastatic Prostate Cancer Treatment Report Years Considered
Figure 10. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metastatic Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2020
Figure 17. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 59. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 60. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 61. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 62. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 63. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 64. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 65. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 66. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 67. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • (Post-pandemic Era) - Global Vinpocetine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 93
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vinpocetine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • (Post-pandemic Era) - Global Vinpocetine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vinpocetine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vaccine Adjuvants growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 109
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vaccine Adjuvants Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 109
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Saffron Extract Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 12-Apr-2021        Price: US 3160 Onwards        Pages: 98
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs